Company News for Sep 30, 2021

• Cintas Corporation’s (CTAS - Free Report) shares rose 0.8% after the company reported first-quarter of fiscal 2022 earnings of $3.11 per share, surpassing the Zacks Consensus Estimate of $2.76.
• Shares of NuCana plc (NCNA - Free Report) surged 17.3% after the company reported that the FDA granted Fast Track designation to its Acelarin (NUC-1031) for the first-line treatment of patients with advanced biliary tract cancer.
• GeoVax Labs, Inc.’s (GOVX - Free Report) shares jumped 8.7% after the company reported the purchase of exclusive rights to PNP Therapeutics' development and commercialization of Gedeptin.
• Shares of Lucid Group, Inc. (LCID - Free Report) surged 7.1% after it kicked off production of its electric vehicles in Casa Grande, Arizona and reported that deliveries would begin in late October.

Highest Returns for Any Asset Class

It’s not even close. Despite ups and downs, Bitcoin has been more profitable for investors than any other decentralized, borderless form of money.

No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%. Zacks predicts another significant surge in months to come.

Hurry, Download Special Report – It’s FREE >>